PNPLA3 and cryohydrocytosis: In conclusion, PNPLA3 and TM6SF2 genetic polymorphisms do not appear as major determinants of liver scarring in Pakistani patients with CHC and may be of more relevance to CLP with dysregulated hepatic fat such as NAFLD.